NB-PP_1170x120

limited-distribution drugs

M&A activity heats up in specialty pharmacy

M&A activity heats up in specialty pharmacy

In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused

Diplomat steps to the fore in specialty Rx

Diplomat steps to the fore in specialty Rx

FLINT, Mich. — Diplomat Pharmacy Inc. is a growing company in a quickly growing industry. The specialty pharmacy provider has made the most of its independence, says chairman and chief executive officer Phil Hagerman, and continues to do so after last year’s initial public offering. Even though Diplomat has become publicly traded, “we absolutely still